JOHN KIRKWOOD to Heat-Shock Proteins
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Heat-Shock Proteins.
Connection Strength
0.070
-
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group. J Clin Oncol. 2008 Feb 20; 26(6):955-62.
Score: 0.070